Although the potential contribution of the human gastrointestinal (GI) tract microbiome to
human health, aging, and disease is becoming increasingly acknowledged, the molecular …

Abundant clinical, epidemiological, imaging, genetic, molecular, and pathophysiological
data together indicate that there occur an unusual inflammatory reaction and a disruption of …

Lipopolysaccharides (LPSs) are microbiome-derived glycolipids that are among the most
potent pro-inflammatory neurotoxins known. In Homo sapiens, the major sources of LPSs …

Several independent laboratories have recently reported the detection of bacterial nucleic
acid sequences or bacterial-derived neurotoxins, such as highly inflammatory …

The human microbiome consists of~ 3.8× 1013 symbiotic microorganisms that form a highly
complex and dynamic ecosystem: the gastrointestinal (GI) tract constitutes the largest …

The microbiome of the human gastrointestinal (GI)-tract is a rich and dynamic source of
microorganisms that together possess a staggering complexity and diversity. Collectively …

Background Increasing evidence links the gut microbiota (GM) to Alzheimer's disease (AD)
but the mechanisms through which gut bacteria influence the brain are still unclear. This …

Accumulating clinical-and scientific research-based evidence is driving our increased
awareness of the significance of the human microbiome (HM) to the healthy and …

One of the most important scientific discoveries of recent years was the disclosure that the
intestinal microflora takes part in bidirectional communication between the gut and the brain …

Lipopolysaccharide (LPS) is a cell-wall immunostimulatory endotoxin component of Gram-
negative bacteria. A growing body of evidence reveals that alterations in the bacterial …